APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Custom Recombinant Protein Production Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Custom Recombinant Protein Production Service Market Analysis and Forecast 2026-2032

Report ID 17410847021 May 2026198 pages

Choose your research edition.

Industry ResearchCustom Recombinant Protein Production Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Recombinant Protein Production Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Custom Recombinant Protein Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Recombinant Protein Production Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Recombinant Protein Production Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Custom Recombinant Protein Production Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Custom Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Custom Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Custom Recombinant Protein Production Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Custom Recombinant Protein Production Service include VectorBuilder, Proteos, Creative Biolabs, Charles River, InVivo BioTech Services GmbH, eEnzyme, BiologicsCorp, Biomatik and RayBiotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Recombinant Protein Production Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Custom Recombinant Protein Production Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Recombinant Protein Production Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Recombinant Protein Production Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Recombinant Protein Production Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Recombinant Protein Production Service revenue, projected growth trends, production technology, application and end-user industry.

Custom Recombinant Protein Production Service Segment by Company

VectorBuilder

Proteos

Creative Biolabs

Charles River

InVivo BioTech Services GmbH

eEnzyme

BiologicsCorp

Biomatik

RayBiotech

R&D Systems

OriGene Technologies

Applied Biological Materials Inc. (abm)

Creative BioMart

Levprot Bioscience

Jubilant Biosys

Kinexus Bioinformatics

NorthX Biologics

Leinco Technologies

GenScript

KACTUS

G &P Biosciences

Boster Bio

Eurofins Discovery

Custom Recombinant Protein Production Service Segment by Type

Mammalian Cell Based

Bacteria Based

Insect Cell Based

Others

Custom Recombinant Protein Production Service Segment by Application

Basic Scientific Research

Monoclonal Antibody Drug Development

Therapeutic Protein Production

Mrna Vaccine Research

Others

Custom Recombinant Protein Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Recombinant Protein Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Recombinant Protein Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Recombinant Protein Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Custom Recombinant Protein Production Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Custom Recombinant Protein Production Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Recombinant Protein Production Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Recombinant Protein Production Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Mammalian Cell Based Major Player Table 3. Bacteria Based Major Player Table 4. Insect Cell Based Major Player Table 5. Others Major Player Table 6. Global Custom Recombinant Protein Production Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Basic Scientific Research Major Player Table 8. Monoclonal Antibody Drug Development Major Player Table 9. Therapeutic Protein Production Major Player Table 10. Mrna Vaccine Research Major Player Table 11. Others Major Player Table 12. Custom Recombinant Protein Production Service Industry Trends Table 13. Custom Recombinant Protein Production Service Industry Drivers Table 14. Custom Recombinant Protein Production Service Industry Opportunities and Challenges Table 15. Custom Recombinant Protein Production Service Industry Restraints Table 16. Global Custom Recombinant Protein Production Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Custom Recombinant Protein Production Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Custom Recombinant Protein Production Service Market Share by Region (2021-2026) Table 19. Global Custom Recombinant Protein Production Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Custom Recombinant Protein Production Service Market Share by Region (2027-2032) Table 21. Global Custom Recombinant Protein Production Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Custom Recombinant Protein Production Service Revenue Market Share by Players (2021-2026) Table 23. Global Custom Recombinant Protein Production Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Custom Recombinant Protein Production Service Key Players Headquarters & Area Served Table 25. Global Custom Recombinant Protein Production Service Players, Product Type & Application Table 26. Global Custom Recombinant Protein Production Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Custom Recombinant Protein Production Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Custom Recombinant Protein Production Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Custom Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Custom Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Custom Recombinant Protein Production Service Revenue Market Share by Type (2021-2026) Table 33. Global Custom Recombinant Protein Production Service Revenue Market Share by Type (2027-2032) Table 34. Global Custom Recombinant Protein Production Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Custom Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Custom Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Custom Recombinant Protein Production Service Revenue Market Share by Application (2021-2026) Table 38. Global Custom Recombinant Protein Production Service Revenue Market Share by Application (2027-2032) Table 39. VectorBuilder Company Information Table 40. VectorBuilder Business Overview Table 41. VectorBuilder Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. VectorBuilder Custom Recombinant Protein Production Service Product Portfolio Table 43. VectorBuilder Recent Development Table 44. Proteos Company Information Table 45. Proteos Business Overview Table 46. Proteos Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Proteos Custom Recombinant Protein Production Service Product Portfolio Table 48. Proteos Recent Development Table 49. Creative Biolabs Company Information Table 50. Creative Biolabs Business Overview Table 51. Creative Biolabs Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Creative Biolabs Custom Recombinant Protein Production Service Product Portfolio Table 53. Creative Biolabs Recent Development Table 54. Charles River Company Information Table 55. Charles River Business Overview Table 56. Charles River Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Charles River Custom Recombinant Protein Production Service Product Portfolio Table 58. Charles River Recent Development Table 59. InVivo BioTech Services GmbH Company Information Table 60. InVivo BioTech Services GmbH Business Overview Table 61. InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Product Portfolio Table 63. InVivo BioTech Services GmbH Recent Development Table 64. eEnzyme Company Information Table 65. eEnzyme Business Overview Table 66. eEnzyme Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. eEnzyme Custom Recombinant Protein Production Service Product Portfolio Table 68. eEnzyme Recent Development Table 69. BiologicsCorp Company Information Table 70. BiologicsCorp Business Overview Table 71. BiologicsCorp Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. BiologicsCorp Custom Recombinant Protein Production Service Product Portfolio Table 73. BiologicsCorp Recent Development Table 74. Biomatik Company Information Table 75. Biomatik Business Overview Table 76. Biomatik Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Biomatik Custom Recombinant Protein Production Service Product Portfolio Table 78. Biomatik Recent Development Table 79. RayBiotech Company Information Table 80. RayBiotech Business Overview Table 81. RayBiotech Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. RayBiotech Custom Recombinant Protein Production Service Product Portfolio Table 83. RayBiotech Recent Development Table 84. R&D Systems Company Information Table 85. R&D Systems Business Overview Table 86. R&D Systems Custom Recombinant Protein Production Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. R&D Systems Custom Recombinant Protein Production Service Product Portfolio Table 88. R&D Systems Recent Development Table 89. OriGene Technologies Company Information Table 90. OriGene Technologies Business Overview Table 91. OriGene Technologies Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. OriGene Technologies Custom Recombinant Protein Production Service Product Portfolio Table 93. OriGene Technologies Recent Development Table 94. Applied Biological Materials Inc. (abm) Company Information Table 95. Applied Biological Materials Inc. (abm) Business Overview Table 96. Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Product Portfolio Table 98. Applied Biological Materials Inc. (abm) Recent Development Table 99. Creative BioMart Company Information Table 100. Creative BioMart Business Overview Table 101. Creative BioMart Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Creative BioMart Custom Recombinant Protein Production Service Product Portfolio Table 103. Creative BioMart Recent Development Table 104. Levprot Bioscience Company Information Table 105. Levprot Bioscience Business Overview Table 106. Levprot Bioscience Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Levprot Bioscience Custom Recombinant Protein Production Service Product Portfolio Table 108. Levprot Bioscience Recent Development Table 109. Jubilant Biosys Company Information Table 110. Jubilant Biosys Business Overview Table 111. Jubilant Biosys Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Jubilant Biosys Custom Recombinant Protein Production Service Product Portfolio Table 113. Jubilant Biosys Recent Development Table 114. Kinexus Bioinformatics Company Information Table 115. Kinexus Bioinformatics Business Overview Table 116. Kinexus Bioinformatics Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Kinexus Bioinformatics Custom Recombinant Protein Production Service Product Portfolio Table 118. Kinexus Bioinformatics Recent Development Table 119. NorthX Biologics Company Information Table 120. NorthX Biologics Business Overview Table 121. NorthX Biologics Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. NorthX Biologics Custom Recombinant Protein Production Service Product Portfolio Table 123. NorthX Biologics Recent Development Table 124. Leinco Technologies Company Information Table 125. Leinco Technologies Business Overview Table 126. Leinco Technologies Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Leinco Technologies Custom Recombinant Protein Production Service Product Portfolio Table 128. Leinco Technologies Recent Development Table 129. GenScript Company Information Table 130. GenScript Business Overview Table 131. GenScript Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. GenScript Custom Recombinant Protein Production Service Product Portfolio Table 133. GenScript Recent Development Table 134. KACTUS Company Information Table 135. KACTUS Business Overview Table 136. KACTUS Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. KACTUS Custom Recombinant Protein Production Service Product Portfolio Table 138. KACTUS Recent Development Table 139. G &P Biosciences Company Information Table 140. G &P Biosciences Business Overview Table 141. G &P Biosciences Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. G &P Biosciences Custom Recombinant Protein Production Service Product Portfolio Table 143. G &P Biosciences Recent Development Table 144. Boster Bio Company Information Table 145. Boster Bio Business Overview Table 146. Boster Bio Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Boster Bio Custom Recombinant Protein Production Service Product Portfolio Table 148. Boster Bio Recent Development Table 149. Eurofins Discovery Company Information Table 150. Eurofins Discovery Business Overview Table 151. Eurofins Discovery Custom Recombinant Protein Production Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Eurofins Discovery Custom Recombinant Protein Production Service Product Portfolio Table 153. Eurofins Discovery Recent Development Table 154. North America Custom Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 155. North America Custom Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 156. North America Custom Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 157. North America Custom Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 158. North America Custom Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. North America Custom Recombinant Protein Production Service Revenue by Country (2021-2026) & (US$ Million) Table 160. North America Custom Recombinant Protein Production Service Revenue by Country (US$ Million) & (2027-2032) Table 161. Europe Custom Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Custom Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Custom Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 164. Europe Custom Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 165. Europe Custom Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Europe Custom Recombinant Protein Production Service Revenue by Country (2021-2026) & (US$ Million) Table 167. Europe Custom Recombinant Protein Production Service Revenue by Country (US$ Million) & (2027-2032) Table 168. China Custom Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 169. China Custom Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 170. China Custom Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 171. China Custom Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Custom Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Custom Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Custom Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Custom Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Custom Recombinant Protein Production Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Custom Recombinant Protein Production Service Revenue by Region (US$ Million) & (2021-2026) Table 178. Asia Custom Recombinant Protein Production Service Revenue by Region (US$ Million) & (2027-2032) Table 179. SAMEA Custom Recombinant Protein Production Service Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Custom Recombinant Protein Production Service Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Custom Recombinant Protein Production Service Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Custom Recombinant Protein Production Service Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Custom Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. SAMEA Custom Recombinant Protein Production Service Revenue by Country (2021-2026) & (US$ Million) Table 185. SAMEA Custom Recombinant Protein Production Service Revenue by Country (US$ Million) & (2027-2032) Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Custom Recombinant Protein Production Service Image Figure 2. Global Custom Recombinant Protein Production Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Recombinant Protein Production Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Mammalian Cell Based Image Figure 5. Bacteria Based Image Figure 6. Insect Cell Based Image Figure 7. Others Image Figure 8. Global Custom Recombinant Protein Production Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Custom Recombinant Protein Production Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Basic Scientific Research Image Figure 11. Monoclonal Antibody Drug Development Image Figure 12. Therapeutic Protein Production Image Figure 13. Mrna Vaccine Research Image Figure 14. Others Image Figure 15. Global Custom Recombinant Protein Production Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Custom Recombinant Protein Production Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Custom Recombinant Protein Production Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Custom Recombinant Protein Production Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Custom Recombinant Protein Production Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Custom Recombinant Protein Production Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Custom Recombinant Protein Production Service Revenue Market Share by Type (2021-2032) Figure 23. Global Custom Recombinant Protein Production Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Custom Recombinant Protein Production Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Custom Recombinant Protein Production Service Revenue Market Share by Application (2021-2032) Figure 26. North America Custom Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 28. North America Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 29. North America Custom Recombinant Protein Production Service Revenue Share by Country (2021-2032) Figure 30. United States Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Custom Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 35. Europe Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 36. Europe Custom Recombinant Protein Production Service Revenue Share by Country (2021-2032) Figure 37. Germany Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Custom Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 47. China Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 48. Asia Custom Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 50. Asia Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 51. Asia Custom Recombinant Protein Production Service Revenue Share by Region (2021-2032) Figure 52. Japan Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Custom Recombinant Protein Production Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Custom Recombinant Protein Production Service Revenue Share by Country (2021-2032) Figure 62. Brazil Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Custom Recombinant Protein Production Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Mammalian Cell Based
  • Bacteria Based
  • Insect Cell Based
  • Others
Applications
  • Basic Scientific Research
  • Monoclonal Antibody Drug Development
  • Therapeutic Protein Production
  • Mrna Vaccine Research
  • Others
Companies covered
  • VectorBuilder
  • Proteos
  • Creative Biolabs
  • Charles River
  • InVivo BioTech Services GmbH
  • eEnzyme
  • BiologicsCorp
  • Biomatik
  • RayBiotech
  • R&D Systems
  • OriGene Technologies
  • Applied Biological Materials Inc. (abm)
  • Creative BioMart
  • Levprot Bioscience
  • Jubilant Biosys
  • Kinexus Bioinformatics
  • NorthX Biologics
  • Leinco Technologies
  • GenScript
  • KACTUS
  • G &P Biosciences
  • Boster Bio
  • Eurofins Discovery

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Custom Recombinant Protein Production Service Market by Type
  3. 1.2.1 Global Custom Recombinant Protein Production Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Mammalian Cell Based
  5. 1.2.3 Bacteria Based
  6. 1.2.4 Insect Cell Based
  7. 1.2.5 Others
  8. 1.3 Custom Recombinant Protein Production Service Market by Application
  9. 1.3.1 Global Custom Recombinant Protein Production Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Basic Scientific Research
  11. 1.3.3 Monoclonal Antibody Drug Development
  12. 1.3.4 Therapeutic Protein Production
  13. 1.3.5 Mrna Vaccine Research
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Custom Recombinant Protein Production Service Market Dynamics
  1. 2.1 Custom Recombinant Protein Production Service Industry Trends
  2. 2.2 Custom Recombinant Protein Production Service Industry Drivers
  3. 2.3 Custom Recombinant Protein Production Service Industry Opportunities and Challenges
  4. 2.4 Custom Recombinant Protein Production Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Custom Recombinant Protein Production Service Market Perspective (2021-2032)
  2. 3.2 Global Custom Recombinant Protein Production Service Growth Trends by Region
  3. 3.2.1 Global Custom Recombinant Protein Production Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Custom Recombinant Protein Production Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Custom Recombinant Protein Production Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Custom Recombinant Protein Production Service Revenue by Players
  2. 4.1.1 Global Custom Recombinant Protein Production Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Custom Recombinant Protein Production Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Custom Recombinant Protein Production Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Custom Recombinant Protein Production Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Custom Recombinant Protein Production Service Key Players Headquarters & Area Served
  7. 4.4 Global Custom Recombinant Protein Production Service Players, Product Type & Application
  8. 4.5 Global Custom Recombinant Protein Production Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Custom Recombinant Protein Production Service Market CR5 and HHI
  11. 4.6.3 2025 Custom Recombinant Protein Production Service Tier 1, Tier 2, and Tier 3
5 Custom Recombinant Protein Production Service Market Size by Type
  1. 5.1 Global Custom Recombinant Protein Production Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 5.3 Global Custom Recombinant Protein Production Service Revenue Market Share by Type (2021-2032)
6 Custom Recombinant Protein Production Service Market Size by Application
  1. 6.1 Global Custom Recombinant Protein Production Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Custom Recombinant Protein Production Service Revenue by Application (2021-2032)
  3. 6.3 Global Custom Recombinant Protein Production Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 VectorBuilder
  2. 7.1.1 VectorBuilder Company Information
  3. 7.1.2 VectorBuilder Business Overview
  4. 7.1.3 VectorBuilder Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 VectorBuilder Custom Recombinant Protein Production Service Product Portfolio
  6. 7.1.5 VectorBuilder Recent Developments
  7. 7.2 Proteos
  8. 7.2.1 Proteos Company Information
  9. 7.2.2 Proteos Business Overview
  10. 7.2.3 Proteos Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Proteos Custom Recombinant Protein Production Service Product Portfolio
  12. 7.2.5 Proteos Recent Developments
  13. 7.3 Creative Biolabs
  14. 7.3.1 Creative Biolabs Company Information
  15. 7.3.2 Creative Biolabs Business Overview
  16. 7.3.3 Creative Biolabs Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative Biolabs Custom Recombinant Protein Production Service Product Portfolio
  18. 7.3.5 Creative Biolabs Recent Developments
  19. 7.4 Charles River
  20. 7.4.1 Charles River Company Information
  21. 7.4.2 Charles River Business Overview
  22. 7.4.3 Charles River Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Custom Recombinant Protein Production Service Product Portfolio
  24. 7.4.5 Charles River Recent Developments
  25. 7.5 InVivo BioTech Services GmbH
  26. 7.5.1 InVivo BioTech Services GmbH Company Information
  27. 7.5.2 InVivo BioTech Services GmbH Business Overview
  28. 7.5.3 InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Product Portfolio
  30. 7.5.5 InVivo BioTech Services GmbH Recent Developments
  31. 7.6 eEnzyme
  32. 7.6.1 eEnzyme Company Information
  33. 7.6.2 eEnzyme Business Overview
  34. 7.6.3 eEnzyme Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 eEnzyme Custom Recombinant Protein Production Service Product Portfolio
  36. 7.6.5 eEnzyme Recent Developments
  37. 7.7 BiologicsCorp
  38. 7.7.1 BiologicsCorp Company Information
  39. 7.7.2 BiologicsCorp Business Overview
  40. 7.7.3 BiologicsCorp Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BiologicsCorp Custom Recombinant Protein Production Service Product Portfolio
  42. 7.7.5 BiologicsCorp Recent Developments
  43. 7.8 Biomatik
  44. 7.8.1 Biomatik Company Information
  45. 7.8.2 Biomatik Business Overview
  46. 7.8.3 Biomatik Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Biomatik Custom Recombinant Protein Production Service Product Portfolio
  48. 7.8.5 Biomatik Recent Developments
  49. 7.9 RayBiotech
  50. 7.9.1 RayBiotech Company Information
  51. 7.9.2 RayBiotech Business Overview
  52. 7.9.3 RayBiotech Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 RayBiotech Custom Recombinant Protein Production Service Product Portfolio
  54. 7.9.5 RayBiotech Recent Developments
  55. 7.10 R&D Systems
  56. 7.10.1 R&D Systems Company Information
  57. 7.10.2 R&D Systems Business Overview
  58. 7.10.3 R&D Systems Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 R&D Systems Custom Recombinant Protein Production Service Product Portfolio
  60. 7.10.5 R&D Systems Recent Developments
  61. 7.11 OriGene Technologies
  62. 7.11.1 OriGene Technologies Company Information
  63. 7.11.2 OriGene Technologies Business Overview
  64. 7.11.3 OriGene Technologies Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 OriGene Technologies Custom Recombinant Protein Production Service Product Portfolio
  66. 7.11.5 OriGene Technologies Recent Developments
  67. 7.12 Applied Biological Materials Inc. (abm)
  68. 7.12.1 Applied Biological Materials Inc. (abm) Company Information
  69. 7.12.2 Applied Biological Materials Inc. (abm) Business Overview
  70. 7.12.3 Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Product Portfolio
  72. 7.12.5 Applied Biological Materials Inc. (abm) Recent Developments
  73. 7.13 Creative BioMart
  74. 7.13.1 Creative BioMart Company Information
  75. 7.13.2 Creative BioMart Business Overview
  76. 7.13.3 Creative BioMart Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Creative BioMart Custom Recombinant Protein Production Service Product Portfolio
  78. 7.13.5 Creative BioMart Recent Developments
  79. 7.14 Levprot Bioscience
  80. 7.14.1 Levprot Bioscience Company Information
  81. 7.14.2 Levprot Bioscience Business Overview
  82. 7.14.3 Levprot Bioscience Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Levprot Bioscience Custom Recombinant Protein Production Service Product Portfolio
  84. 7.14.5 Levprot Bioscience Recent Developments
  85. 7.15 Jubilant Biosys
  86. 7.15.1 Jubilant Biosys Company Information
  87. 7.15.2 Jubilant Biosys Business Overview
  88. 7.15.3 Jubilant Biosys Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Jubilant Biosys Custom Recombinant Protein Production Service Product Portfolio
  90. 7.15.5 Jubilant Biosys Recent Developments
  91. 7.16 Kinexus Bioinformatics
  92. 7.16.1 Kinexus Bioinformatics Company Information
  93. 7.16.2 Kinexus Bioinformatics Business Overview
  94. 7.16.3 Kinexus Bioinformatics Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Kinexus Bioinformatics Custom Recombinant Protein Production Service Product Portfolio
  96. 7.16.5 Kinexus Bioinformatics Recent Developments
  97. 7.17 NorthX Biologics
  98. 7.17.1 NorthX Biologics Company Information
  99. 7.17.2 NorthX Biologics Business Overview
  100. 7.17.3 NorthX Biologics Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 NorthX Biologics Custom Recombinant Protein Production Service Product Portfolio
  102. 7.17.5 NorthX Biologics Recent Developments
  103. 7.18 Leinco Technologies
  104. 7.18.1 Leinco Technologies Company Information
  105. 7.18.2 Leinco Technologies Business Overview
  106. 7.18.3 Leinco Technologies Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Leinco Technologies Custom Recombinant Protein Production Service Product Portfolio
  108. 7.18.5 Leinco Technologies Recent Developments
  109. 7.19 GenScript
  110. 7.19.1 GenScript Company Information
  111. 7.19.2 GenScript Business Overview
  112. 7.19.3 GenScript Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 GenScript Custom Recombinant Protein Production Service Product Portfolio
  114. 7.19.5 GenScript Recent Developments
  115. 7.20 KACTUS
  116. 7.20.1 KACTUS Company Information
  117. 7.20.2 KACTUS Business Overview
  118. 7.20.3 KACTUS Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 KACTUS Custom Recombinant Protein Production Service Product Portfolio
  120. 7.20.5 KACTUS Recent Developments
  121. 7.21 G &P Biosciences
  122. 7.21.1 G &P Biosciences Company Information
  123. 7.21.2 G &P Biosciences Business Overview
  124. 7.21.3 G &P Biosciences Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 G &P Biosciences Custom Recombinant Protein Production Service Product Portfolio
  126. 7.21.5 G &P Biosciences Recent Developments
  127. 7.22 Boster Bio
  128. 7.22.1 Boster Bio Company Information
  129. 7.22.2 Boster Bio Business Overview
  130. 7.22.3 Boster Bio Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Boster Bio Custom Recombinant Protein Production Service Product Portfolio
  132. 7.22.5 Boster Bio Recent Developments
  133. 7.23 Eurofins Discovery
  134. 7.23.1 Eurofins Discovery Company Information
  135. 7.23.2 Eurofins Discovery Business Overview
  136. 7.23.3 Eurofins Discovery Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Eurofins Discovery Custom Recombinant Protein Production Service Product Portfolio
  138. 7.23.5 Eurofins Discovery Recent Developments
8 North America
  1. 8.1 North America Custom Recombinant Protein Production Service Revenue (2021-2032)
  2. 8.2 North America Custom Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Custom Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Custom Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 8.3 North America Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Custom Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Custom Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Custom Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 8.5 North America Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Custom Recombinant Protein Production Service Revenue by Country
  11. 8.6.1 North America Custom Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Custom Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Custom Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Custom Recombinant Protein Production Service Revenue (2021-2032)
  2. 9.2 Europe Custom Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Custom Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Custom Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 9.3 Europe Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Custom Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Custom Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Custom Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 9.5 Europe Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Custom Recombinant Protein Production Service Revenue by Country
  11. 9.6.1 Europe Custom Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Custom Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Custom Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Custom Recombinant Protein Production Service Revenue (2021-2032)
  2. 10.2 China Custom Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 10.2.1 China Custom Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 10.2.2 China Custom Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 10.3 China Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 10.4 China Custom Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 10.4.1 China Custom Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 10.4.2 China Custom Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 10.5 China Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Custom Recombinant Protein Production Service Revenue (2021-2032)
  2. 11.2 Asia Custom Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Custom Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Custom Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 11.3 Asia Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Custom Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Custom Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Custom Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 11.5 Asia Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Custom Recombinant Protein Production Service Revenue by Country
  11. 11.6.1 Asia Custom Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Custom Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Custom Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Custom Recombinant Protein Production Service Revenue (2021-2032)
  2. 12.2 SAMEA Custom Recombinant Protein Production Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Custom Recombinant Protein Production Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Custom Recombinant Protein Production Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Custom Recombinant Protein Production Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Custom Recombinant Protein Production Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Custom Recombinant Protein Production Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Custom Recombinant Protein Production Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Custom Recombinant Protein Production Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Custom Recombinant Protein Production Service Revenue by Country
  11. 12.6.1 SAMEA Custom Recombinant Protein Production Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Custom Recombinant Protein Production Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Custom Recombinant Protein Production Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst